BACKGROUND: A wide range of potentially modifiable risk factors, indicating that the onset of neurocognitive disorders can be delayed or prevented, have been identified. The region of Central and Eastern Europe has cultural, political and economic specifics that may influence the occurrence of risk factors and their link to the cognitive health of the population. OBJECTIVE: We aimed to systematically review population-based studies from Central and Eastern Europe to gather evidence on risk and protective factors for neurocognitive disorders. METHODS: We searched the electronic databases PubMed, Cochrane Database of Systematic Reviews, PsycINFO, Web of Science, and Embase. The search was performed on 26th of February 2020 and repeated at the end of the review process on 20th May 2021. RESULTS: We included 25 papers in a narrative synthesis of the evidence describing cardiovascular risk factors (n = 7), social factors (n = 5), oxidative stress (n = 2), vitamins (n = 2), genetic factors (n = 2) and other areas (n = 7). We found that there was a good body of evidence on the association between neurocognitive disorders and the history of cardiovascular disease while there were gaps in research of genetic and social risk factors. CONCLUSION: We conclude that the epidemiological evidence from this region is insufficient and population-based prospectively followed cohorts should be established to allow the development of preventive strategies at national levels.

Department of Epidemiology 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Psychiatry and Medical Psychology 3rd Faculty of Medicine Charles University Prague Czech Republic

National Institute of Mental Health Klecany Czech Republic

Zobrazit více v PubMed

Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al.. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. The Lancet Neurology. 2016;15(5):455–532. doi: 10.1016/S1474-4422(16)00062-4 PubMed DOI

Prince M, Comas-Herrera A, Knapp M, Guerchet Ml, Karagiannidou M. The World Alzheimer Report 2016. London: Alzheimer’s Disease International, 2016.

Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Archives of neurology. 2001;58(3):411–6. doi: 10.1001/archneur.58.3.411 PubMed DOI

Lavery LL, Dodge HH, Snitz B, Ganguli M. Cognitive decline and mortality in a community‐based cohort: the Monongahela Valley Independent Elders Survey. Journal of the American Geriatrics Society. 2009;57(1):94–100. doi: 10.1111/j.1532-5415.2008.02052.x PubMed DOI PMC

Leibson CL, Long KH, Ransom JE, Roberts RO, Hass SL, Duhig AM, et al.. Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study. Alzheimer’s & Dementia. 2015;11(8):917–32. doi: 10.1016/j.jalz.2015.01.007 PubMed DOI PMC

Hill NL, McDermott C, Mogle J, Munoz E, DePasquale N, Wion R, et al.. Subjective cognitive impairment and quality of life: a systematic review. International Psychogeriatrics. 2017;29(12):1965–77. doi: 10.1017/S1041610217001636 PubMed DOI

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al.. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413–46. PubMed PMC

World Health Organization. Dementia: a public health priority: World Health Organization; 2012.

Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Munoz Sanchez JL, Anstey KJ, et al.. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. International journal of geriatric psychiatry. 2015;30(3):234–46. doi: 10.1002/gps.4245 PubMed DOI

Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. The Lancet Neurology. 2014;13(8):788–94. doi: 10.1016/S1474-4422(14)70136-X PubMed DOI

Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nature Reviews Cardiology. 2015;12(5):267. doi: 10.1038/nrcardio.2014.223 PubMed DOI

Fratiglioni L, Marseglia A, Dekhtyar S. Ageing without dementia: can stimulating psychosocial and lifestyle experiences make a difference? The Lancet Neurology. 2020;19(6):533–43. doi: 10.1016/S1474-4422(20)30039-9 PubMed DOI

Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer’s disease. Jama. 1994;271(13):1004–10. PubMed

Zissimopoulos J, Crimmins E, Clair PS, editors. The value of delaying Alzheimer’s disease onset. Forum for health economics & policy; 2015: De Gruyter. PubMed PMC

Wu YT, Fratiglioni L, Matthews FE, Lobo A, Breteler MM, Skoog I, et al.. Dementia in western Europe: epidemiological evidence and implications for policy making. The Lancet Neurology. 2016;15(1):116–24. Epub 2015/08/25. doi: 10.1016/S1474-4422(15)00092-7 . PubMed DOI

Wu YT, Beiser AS, Breteler MMB, Fratiglioni L, Helmer C, Hendrie HC, et al.. The changing prevalence and incidence of dementia over time—current evidence. Nature reviews Neurology. 2017;13(6):327–39. Epub 2017/05/13. doi: 10.1038/nrneurol.2017.63 . PubMed DOI

Sosa AL, Albanese E, Stephan BC, Dewey M, Acosta D, Ferri CP, et al.. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS medicine. 2012;9(2):e1001170. doi: 10.1371/journal.pmed.1001170 PubMed DOI PMC

Bobak M, Marmot M. East-West mortality divide and its potential explanations: proposed research agenda. Bmj. 1996;312(7028):421–5. Epub 1996/02/17. doi: 10.1136/bmj.312.7028.421 ; PubMed Central PMCID: PMC2350098. PubMed DOI PMC

Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, et al.. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC public health. 2006;6:255. Epub 2006/10/20. doi: 10.1186/1471-2458-6-255 ; PubMed Central PMCID: PMC1626086. PubMed DOI PMC

Boylan S, Welch A, Pikhart H, Malyutina S, Pajak A, Kubinova R, et al.. Dietary habits in three Central and Eastern European countries: the HAPIEE study. BMC public health. 2009;9(1):439. doi: 10.1186/1471-2458-9-439 PubMed DOI PMC

Kozela M, Bobak M, Besala A, Micek A, Kubinova R, Malyutina S, et al.. The association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: Prospective results of the HAPIEE study. European journal of preventive cardiology. 2016;23(17):1839–47. Epub 2016/10/30. doi: 10.1177/2047487316649493 ; PubMed Central PMCID: PMC5089224. PubMed DOI PMC

Enache D, Fereshtehnejad SM, Kareholt I, Cermakova P, Garcia-Ptacek S, Johnell K, et al.. Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry. Acta psychiatrica Scandinavica. 2016;134(5):430–40. Epub 2016/09/03. doi: 10.1111/acps.12630 . PubMed DOI

Cifkova R, Skodova Z, Lanska V, Adamkova V, Novozamska E, Petrzilkova Z, et al.. Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. Journal of hypertension. 2004;22(8):1479–85. Epub 2004/07/17. doi: 10.1097/01.hjh.0000133737.77866.3e . PubMed DOI

Cifkova R, Skodova Z, Bruthans J, Adamkova V, Jozifova M, Galovcova M, et al.. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 2010;211(2):676–81. Epub 2010/05/18. doi: 10.1016/j.atherosclerosis.2010.04.007 . PubMed DOI

Cifkova R, Skodova Z, Bruthans J, Holub J, Adamkova V, Jozifova M, et al.. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. Journal of hypertension. 2010;28(11):2196–203. Epub 2010/07/24. doi: 10.1097/HJH.0b013e32833d4451 . PubMed DOI

Cermakova P, Formanek T, Kagstrom A, Winkler P. Socioeconomic position in childhood and cognitive aging in Europe. Neurology. 2018;91(17):E1602–E10. doi: 10.1212/WNL.0000000000006390 . PubMed DOI PMC

Formanek T, Kagstrom A, Winkler P, Cermakova P. Differences in cognitive performance and cognitive decline across European regions: a population-based prospective cohort study. European Psychiatry. 2019;58:80–6. Epub 2019/03/16. doi: 10.1016/j.eurpsy.2019.03.001 . PubMed DOI

OECD. Agricultural Policies in OECD Countries: Monitoring and Evaluation 2000: Glossary of Agricultural Policy Terms. Available from: https://stats.oecd.org/glossary/detail.asp?ID=303.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Systematic Reviews. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4 PubMed DOI PMC

Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53. Epub 2015/09/01. doi: 10.1097/XEB.0000000000000054 . PubMed DOI

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. Epub 2009/07/22. doi: 10.1371/journal.pmed.1000097 ; PubMed Central PMCID: PMC2707599. PubMed DOI PMC

Tamosiunas A, Baceviciene M, Reklaitiene R, Radisauskas R, Jureniene K, Azaraviciene A, et al.. Cardiovascular risk factors and cognitive function in middle aged and elderly Lithuanian urban population: results from the HAPIEE study. BMC Neurol. 2012;12:149. Epub 2012/12/04. doi: 10.1186/1471-2377-12-149 ; PubMed Central PMCID: PMC3517768. PubMed DOI PMC

Horvat P, Richards M, Kubinova R, Pajak A, Malyutina S, Shishkin S, et al.. Alcohol consumption, drinking patterns, and cognitive function in older Eastern European adults. Neurology. 2015;84(3):287–95. Epub 2014/12/17. doi: 10.1212/WNL.0000000000001164 ; PubMed Central PMCID: PMC4335999. PubMed DOI PMC

Pajak A, Kawalec E, Pomykalska E, Topór-Madry R, Orłowiejska-Gillert M, Szczudlik A. [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. IV. Prevalence of cognitive impairment in relation to age, sex, education and history of myocardial infarction in men and women at age 65–78, residents of a rural province in Poland (Tarnobrzed)]. Przegl Lek. 1998;55(12):697–704. Epub 1999/06/04. . PubMed

Kostka T, Para J, Kostka B. Correlates of plasma fibrinogen (FG) levels in a random sample of community-dwelling elderly. Arch Gerontol Geriatr. 2008;46(2):211–20. Epub 2007/05/29. doi: 10.1016/j.archger.2007.03.011 . PubMed DOI

Szcześniak D, Rymaszewska J, Zimny A, Sąsiadek M, Połtyn-Zaradna K, Smith EE, et al.. "Cerebral small vessel disease and other influential factors of cognitive impairment in the middle-aged: a long-term observational cohort PURE-MIND study in Poland". Geroscience. 2021;43(1):279–95. Epub 2020/10/20. doi: 10.1007/s11357-020-00271-4 ; PubMed Central PMCID: PMC8050144. PubMed DOI PMC

Puzianowska-Kuznicka M, Kuryłowicz A, Walkiewicz D, Borkowska J, Owczarz M, Olszanecka-Glinianowicz M, et al.. Obesity Paradox in Caucasian Seniors: Results of the PolSenior Study. J Nutr Health Aging. 2019;23(9):796–804. Epub 2019/10/24. doi: 10.1007/s12603-019-1257-z ; PubMed Central PMCID: PMC6800404. PubMed DOI PMC

Tournoy J, Lee DM, Pendleton N, O’Neill TW, O’Connor DB, Bartfai G, et al.. Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European Male Ageing Study. Diabetes Metab Res Rev. 2010;26(8):668–76. Epub 2010/11/03. doi: 10.1002/dmrr.1144 . PubMed DOI

Horvat P, Richards M, Malyutina S, Pajak A, Kubinova R, Tamosiunas A, et al.. Life course socioeconomic position and mid-late life cognitive function in Eastern Europe. J Gerontol B Psychol Sci Soc Sci. 2014;69(3):470–81. Epub 2014/03/07. doi: 10.1093/geronb/gbu014 ; PubMed Central PMCID: PMC3983917. PubMed DOI PMC

Klich-Rączka A, Piotrowicz K, Mossakowska M, Skalska A, Wizner B, Broczek K, et al.. The assessment of cognitive impairment suspected of dementia in Polish elderly people: results of the population-based PolSenior Study. Exp Gerontol. 2014;57:233–42. Epub 2014/06/18. doi: 10.1016/j.exger.2014.06.003 . PubMed DOI

Bjelajac AK, Bobić J, Kovačić J, Varnai VM, Macan J, Smolić Š. Employment status and other predictors of mental health and cognitive functions in older Croatian workers. Arh Hig Rada Toksikol. 2019;70(2):109–17. Epub 2019/06/28. doi: 10.2478/aiht-2019-70-3254 . PubMed DOI

Stepankova Georgi H, Frydrychova Z, Horakova Vlckova K, Vidovicova L, Sulc Z, Lukavsky J. Young-Old City-Dwellers Outperform Village Counterparts in Attention and Verbal Control Tasks. Front Psychol. 2019;10:1224. Epub 2019/06/14. doi: 10.3389/fpsyg.2019.01224 ; PubMed Central PMCID: PMC6546844. PubMed DOI PMC

Tosheva E. Participation in Activities: Determinants and Reflection on Quality of Life and Satisfaction in Old Age Population in Bulgaria. Revista Inclusiones. 2020;7:353–67.

Horvat P, Kubinova R, Pajak A, Tamosiunas A, Schöttker B, Pikhart H, et al.. Blood-Based Oxidative Stress Markers and Cognitive Performance in Early Old Age: The HAPIEE Study. Dement Geriatr Cogn Disord. 2016;42(5–6):297–309. Epub 2016/11/02. doi: 10.1159/000450702 ; PubMed Central PMCID: PMC5121567. PubMed DOI PMC

Bednarska-Makaruk M, Rodo M, Szirkowiec W, Mossakowska M, Puzianowska-Kuźnicka M, Skalska A, et al.. Paraoxonase 1 activity and level of antibodies directed against oxidized low density lipoproteins in a group of an elderly population in Poland—PolSenior study. Arch Gerontol Geriatr. 2015;60(1):153–61. Epub 2014/12/03. doi: 10.1016/j.archger.2014.10.010 . PubMed DOI

Horvat P, Gardiner J, Kubinova R, Pajak A, Tamosiunas A, Schöttker B, et al.. Serum folate, vitamin B-12 and cognitive function in middle and older age: The HAPIEE study. Exp Gerontol. 2016;76:33–8. Epub 2016/01/26. doi: 10.1016/j.exger.2016.01.011 ; PubMed Central PMCID: PMC4839985. PubMed DOI PMC

Lee DM, Tajar A, Ulubaev A, Pendleton N, O’Neill TW, O’Connor DB, et al.. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry. 2009;80(7):722–9. Epub 2009/05/23. doi: 10.1136/jnnp.2008.165720 . PubMed DOI

Golanska E, Sieruta M, Gresner SM, Pfeffer A, Chodakowska-Zebrowska M, Sobow TM, et al.. APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians. Exp Gerontol. 2013;48(4):391–4. Epub 2013/02/07. doi: 10.1016/j.exger.2013.01.013 . PubMed DOI

Golanska E, Sieruta M, Corder E, Gresner SM, Pfeffer A, Chodakowska-Zebrowska M, et al.. The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians. Prion. 2013;7(3):244–7. Epub 2013/02/15. doi: 10.4161/pri.23903 ; PubMed Central PMCID: PMC3783110. PubMed DOI PMC

Bdzan LB, Turczyński J, Szabert K. [Prevalence of dementia in a rural population]. Psychiatr Pol. 2007;41(2):181–8. Epub 2007/06/30. . PubMed

Pac A, Tobiasz-Adamczyk B, Błędowski P, Skalska A, Szybalska A, Zdrojewski T, et al.. Influence of Sociodemographic, Behavioral and Other Health-Related Factors on Healthy Ageing Based on Three Operative Definitions. The journal of nutrition, health & aging. 2019;23(9):862–9. doi: 10.1007/s12603-019-1243-5 PubMed DOI PMC

Bobak M, Richards M, Malyutina S, Kubinova R, Peasey A, Pikhart H, et al.. Association between year of birth and cognitive functions in Russia and the Czech Republic: cross-sectional results of the HAPIEE study. Neuroepidemiology. 2009;33(3):231–9. Epub 2009/07/31. doi: 10.1159/000229777 ; PubMed Central PMCID: PMC2826446. PubMed DOI PMC

Lee DM, Tajar A, Ulubaev A, Pendleton N, O’Neill TW, O’Connor DB, et al.. The association between different cognitive domains and age in a multi-centre study of middle-aged and older European men. Int J Geriatr Psychiatry. 2009;24(11):1257–66. Epub 2009/03/26. doi: 10.1002/gps.2255 . PubMed DOI

Seblova D, Brayne C, Machů V, Kuklová M, Kopecek M, Cermakova P. Changes in Cognitive Impairment in the Czech Republic. J Alzheimers Dis. 2019;72(3):693–701. Epub 2019/10/15. doi: 10.3233/JAD-190688 . PubMed DOI

Schmachtenberg T, Monsees J, Hoffmann W, van den Berg N, Stentzel U, Thyrian JR. Comparing national dementia plans and strategies in Europe—is there a focus of care for people with dementia from a migration background? BMC Public Health. 2020;20(1):784. Epub 2020/05/28. doi: 10.1186/s12889-020-08938-5 ; PubMed Central PMCID: PMC7249632. PubMed DOI PMC

Wolters FJ, Yang Q, Biggs ML, Jakobsdottir J, Li S, Evans DS, et al.. The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE). PLOS ONE. 2019;14(7):e0219668. doi: 10.1371/journal.pone.0219668 PubMed DOI PMC